RSS

INM InMed Pharmaceuticals, Inc.

Mod: wholelotamoney
Last Post: 06/24/25
Followers: 5
Posts Today: 0
Views Today: 19

INM Stock Quote & Tools

Company Profile Buy Rating Time & Sales News Filings Financials

INM Stock Message Board Discussion

  1. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical

  2. NetworkNewsWire

    InMed Pharmaceuticals Inc.s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimers

  3. NetworkNewsWire

    InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimers

  4. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent

  5. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data

  6. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc.s (NASDAQ: INM) INM-089 Showing Great Promise in

  7. NetworkNewsWire

    InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on

  8. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results

  9. NetworkNewsWire

    InMed Pharmaceuticals Inc.s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related

  10. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements

  11. NetworkNewsWire

    InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative

  12. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming

  13. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial

  14. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in

  15. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from

  16. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from

  17. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ

  18. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2

  19. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial

  20. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at January Water

  21. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update,

  22. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors

  23. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q1 Fiscal 2024 Financial

  24. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present Phase 2 Study Results

  25. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement

  26. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private

  27. znewcar1

    $INM 70% v102M c.9891 f3,328M Hod2.08 ML=LL.45 gapNcrap

  28. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following

  29. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares

  30. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water

  31. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare

  32. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc.s (NASDAQ: INM) 755-201-EB Trial Demonstrates

  33. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at

  34. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in

  35. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water

  36. znewcar1

    $INM 20% v575K c1.39 f3,328M H1.45 ML1.11

  37. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial

  38. znewcar1

    $INM 38% v22,1M c1.46 f3,328M H1.68 ML.92

  39. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results

  40. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial,

  41. znewcar1

    $INM 36% v4,4M c2.30 f1,589M H2.41 ML1.23

  42. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023

  43. znewcar1

    $INM 27% v2,7M c2.02 f1,590M H2.39 ML1.23 YL1.34 with spikes th HH

  44. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting

  45. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial

  46. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private

  47. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private

  48. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP,

  49. znewcar1

    $INM 36% v28,3M c3.79 f936,761 H4.75 ML2.4 YL2.54

  50. NetworkNewsWire

    NetworkNewsBreaks InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding,